Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarctionGUTSTEIN, D. E; FUSTER, V.Clinical cardiology (Mahwah, NJ). 1998, Vol 21, Num 3, pp 161-168, issn 0160-9289Article

Nontraumatic intramural hematoma of the duodenum complicating warfarin therapyGUTSTEIN, D. E; ROSENBERG, S. J.The Mount Sinai journal of medicine. 1997, Vol 64, Num 4-5, pp 339-341, issn 0027-2507Article

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionGUTSTEIN, D. E; KRISHNA, R; JOHNS, D et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 1, pp 109-122, issn 0009-9236, 14 p.Article

Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathyKAPELKO, V. I; WILLIAMS, C. P; GUTSTEIN, D. E et al.Archives of physiology and biochemistry. 1996, Vol 104, Num 2, pp 185-191, issn 1381-3455Article

Pathophysiology and clinical significance of atherosclerotic plaque ruptureGUTSTEIN, D. E; FUSTER, V.Cardiovascular research. 1999, Vol 41, Num 2, pp 323-333, issn 0008-6363Article